COSCIENS Biopharma Inc (CSCI)

[Runners123]

_____AEZS____ for longs a must read. August 11, 2015
PR:
As you can see, there are two different tones in the PR which caused some confusion. First the PR says the DSMB review "Will be complete" in early October BUT it also says the DSMB will "Conduct the review in October". Therefore, the October 9th submittal deadline for the October 21st DSMB meeting IMHO looked correct. I only wished to share what I found, according to this, the review did NOT start in September as some believe:

Paragraph 1: "will complete a pre-specified second interim efficacy and safety analysis of the compound in early October 2015"

Paragraph #2: "We are informed that the DSMB will conduct its review of the data in early October of this year, and we expect to be able to announce the results of the review soon thereafter."

If the DSMB news comes out in EARLY October that's great, however, I simply tried to share what the DSMB meeting schedule was. No matter if the data is reviewed during the October 21st meeting (as I believe) or if it ocurred during the September 16th meeting (as others believe). The end result will be the same. The point of my post was simply to let other shareholders know that if news was NOT released in EARLY October, stay calm because there is a reason why (meeting schedule) and it has NOTHING to do with the results of the ZopTEC trial.

You know who you are, and I would especially like to thank you for the warm welcome to the AEZS family, arguing over petty things that in the end really don't matter is a waste of time, energy and I'll be sure to make this my last post. I hope that you're right and the announcement occurs ASAP. GLTA Less
Sentiment: Strong Buy